Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation

Sitagliptin is an emerging oral hypoglycemic agent that inhibits the development of a wide variety of tumors. Current researches indicate that the abnormal activation of Yes‐associated protein (YAP) promotes the proliferation and poor prognosis of multiple tumors. However, the ability of sitagliptin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Lu, Pan, Wang, Tao, Zheng, Qianqian, Li, Yan, Leng, Sean X., Meng, Xin, Wang, Biao, Xie, Jisheng, Zhang, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286447/
https://www.ncbi.nlm.nih.gov/pubmed/32227453
http://dx.doi.org/10.1002/cam4.3024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286447/
https://www.ncbi.nlm.nih.gov/pubmed/32227453
http://dx.doi.org/10.1002/cam4.3024

Ejemplares similares